SCHEMBL13697086

SCHEMBL13697086

C[Si](C)(C)c1ccc2cc(-c3c4ccccc4c(-c4ccc([Si](c5ccccc5)(c5ccccc5)c5ccccc5)cc4)c4ccccc34)ccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 8/20 0.37
▸ ESR2 Q92731 6/20 0.37
▸ GPR84 Q9NQS5 1/20 0.33
▸ IKBKB O14920 1/20 0.33
▸ CYP1A2 P05177 4/20 0.33
▸ SMN1; SMN2 Q16637 4/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ AKR1C3 P42330 1/20 0.32
▸ AKR1C2 P52895 1/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ TSHR P16473 1/20 0.32
▸ ALOX5 P09917 1/20 0.32
▸ CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL125736 0.91 ESR1 (0.42) ESR1ESR2GPR84IKBKBCYP1A2
SCHEMBL13162155 0.89 ESR1 (0.39) ESR1ESR2GPR84IKBKBCYP1A2
SCHEMBL16521366 0.88 ESR1 (0.42) ESR1ESR2GPR84IKBKBCYP1A2
SCHEMBL13162178 0.87 ESR1 (0.38) ESR1ESR2GPR84IKBKBCYP1A2
SCHEMBL13162139 0.87 ESR1 (0.45) ESR1ESR2GPR84IKBKBCYP1A2
SCHEMBL125705 0.86 ESR1 (0.43) ESR1ESR2GPR84IKBKBCYP1A2
SCHEMBL124687 0.86 ESR1 (0.43) ESR1ESR2GPR84IKBKBCYP1A2
SCHEMBL13162158 0.86 ESR1 (0.41) ESR1ESR2CYP1A2CYP3A4CYP2C9
SCHEMBL13162140 0.86 ESR1 (0.44) ESR1ESR2GPR84IKBKBCYP1A2
SCHEMBL13162138 0.86 ESR1 (0.40) ESR1ESR2GPR84IKBKBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090236975-A1 SILICON-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE UTILIZING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2009-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090236975-A1 SILICON-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE UTILIZING THE SAME ESPL1, EML4, EED ESR1 102/4885ESR2 252/4885GPR84 4709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback